Treatment of chondrosarcoma cells with increasing concentrations of shikonin derivatives (0.5, 2.5, 5, or 10 μM) for 24 h resulted in an increase of DcR2 and TNF-R2 expression. The gene discussed is TNFRSF1B; the disease is chondrosarcoma.